Related Experiment Video
Updated: Jun 29, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
The CHOICE (Choice of Health Options In prevention of Cardiovascular Events) replication trial: study protocol
Lis Neubeck1, Julie Redfern, Tom Briffa
1Faculty of Medicine, University of Sydney, Sydney, Australia. lneubeck@med.usyd.edu.au
Insights
The CHOICE program, a secondary prevention strategy for coronary heart disease (CHD) survivors, is being tested for replication across multiple sites. This study evaluates if extended reinforcement improves risk factor modification in acute coronary syndrome (ACS) patients.
Area of Science:
- Cardiology
- Public Health
- Preventive Medicine
Background:
- Coronary heart disease (CHD) poses significant mortality and morbidity risks.
- Few acute coronary syndrome (ACS) survivors engage in effective secondary prevention.
- The CHOICE program has demonstrated prior success in risk factor modification.
Purpose of the Study:
- To assess the replicability of the CHOICE program across multiple centers.
- To determine if extended reinforcement in the CHOICE program enhances risk factor modification.
- To evaluate the long-term effectiveness of a modular secondary prevention strategy for CHD.
Main Methods:
- A multi-center, randomized controlled trial design.
- Participants not accessing standard cardiac rehabilitation will be randomized to a 3-month CHOICE program or a 30-month CHOICE-plus program.
- Both groups receive individualized risk factor modules with telephone follow-up; CHOICE-plus includes additional reinforcement.
- Primary outcomes include lipid levels, blood pressure, physical activity, and smoking rates over three years.
Main Results:
- This section is not available in the provided abstract.
Conclusions:
- Presents the rationale and design for a multi-center study.
- Tests a modular approach for secondary prevention of CHD post-ACS.
- Aims to validate the CHOICE program's replicability and the impact of extended reinforcement.
Background:
Although morbidity and mortality from coronary heart disease (CHD) are high, only a minority of acute coronary syndrome (ACS) survivors accesses an effective secondary prevention program. We aim to determine whether the previously proven CHOICE program can be replicated at multiple sites and whether ongoing reinforcement further improves risk factor modification.
Methods/Design:
Participants eligible for but not accessing standard cardiac rehabilitation will be randomly allocated to either a previously tested 3-month CHOICE program or a 30-month CHOICE program (CHOICE-plus). Both groups will participate in individualised risk factor modules of differing duration that involve choice, goal setting and telephone follow-up for three months. CHOICE-plus will also receive additional face-to-face and telephone reinforcement between three and 30 months. At one site we will recruit a randomised control group, receiving conventional care. Primary outcomes are lipid levels, blood pressure, physical activity levels and smoking rates. Secondary outcomes include readmission rates, death, the number of risk factors, other modifiable risk factors, quality of life and process evaluation measures over three years.
Discussion:
We present the rationale and design of a multi-centre, replication study testing a modular approach for the secondary prevention of CHD following an ACS.
Trial Registration:
[Clinical Trial Registration Number, ACTRN12608000182392].
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Bioavailability Study Design: Healthy Subjects Versus Patients
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
What is an Experiment?
Coronary Artery Disease V: Interprofessional Care